Fifty four patients with MDS as defined by the FAB criteria'" modified by May et al" were included in this study, together with 43 haematologically normal subjects undergoing cardiac surgery. The protocols were approved by the South Glamorgan joint ethical committee. In the case of patients bone marrow aspirates were used for analysis and in surgical patients marrow samples were obtained from the exposed surface of the sternum during the operation.
SUMMARY DNA index (DI) determined by flow cytometry and karyotype determined by conventional methods were obtained on bone marrow samples from 43 haematologically normal subjects and 54 patients with myelodysplastic syndrome (MDS). Twenty one patients had a clonal karyotype abnormality but an additional five had a DI outside the normal range, showing evidence of aneuploidy that was not available from chromsome preparations. When patients were grouped into those with excess chromosomal material, those with diploid karyotypes, and those with a loss of chromosomal material, there was a significant difference among the mean DIs of each group, normal subjects being different from all patient groups. In these patients DI measurements were of value when carried out together with conventional chromsomal analysis in gaining the maximum amount of genetic information when a satisfactory karyotype might not be available or where failure of an abnormal cell population to proliferate might give an incomplete cytogenetic picture. The contribution of non-clonal chromsome loss to the DI is probably significant but has not been quantitated. Cytogenetic 
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Fifty four patients with MDS as defined by the FAB criteria'" modified by May et al" were included in this study, together with 43 haematologically normal subjects undergoing cardiac surgery. The protocols were approved by the South Glamorgan joint ethical committee. In the case of patients bone marrow aspirates were used for analysis and in surgical patients marrow samples were obtained from the exposed surface of the sternum during the operation.
Bone marrow aspirates from patients with MDS were placed in 10 ml RPMI 1640 medium (Gibco) containing 15% fetal calf serum (Gibco) at a concentration of 1-1 5 x I07 nucleated cells/ml. The cultures were incubated for two hours in the presence of colcemid (1 ug/ml), for 24 hours with colcemid present, from three-24 hours and for 24 hours with colcemid present for one hour before harvesting. Hypotonic treatment consisted of 0-075M potassium chloride, for 20 minutes. Fixation comprised three changes of methanol:glacial acetic acid (3:1), overnight storage ofthe cells in fixative at -20°C, followed by a further wash in fixative. Slides were prepared and examined using trypsin/Leishmann (GTL) banding. Slides from each culture were assessed and where possible analysed. A minimum of five G-banded metaphases from two or more cultures was necessary for a successful analysis. ofpatients were significantly different from each other, those with a pseudo/hyperdiploid karyotype having a higher (p = 0 0039) and those with a pseudo/hypodiploid karyotype having a lower (p = 0-0008) DI than diploid patients. The mean DI of patients with a diploid karyotype was significantly lower than that of normal subjects (p = 0006). Thirty three of the patients with myelodysplasia had a pseudo/diploid karyotype on cytogenetic analysis but of these, five had a DI outside the range of normal results (fig 2) . Four of 10 patients with an excess of chromosomal material had a DI higher than that of normal subjects and three of 11 patients showing loss of chromsome material had a DI less than that of normal subjects. In total, 21 of 54 patients had a clonal karyotype abnormality, ofwhom seven had an abnormal DI, and 12 of the 54 patients had a DI outside the normal range, seven of whom had a clonal karyotype abnormality. Twenty six patients had either one or both abnormalities. Among the pseudo/hyperdiploid group, two of four patients with a high DI had a constitutional 47,XXY and 47,XXX karyotype, respectively. In one all meta- There was a significant difference between the DI of diploid, pseudo/hyperdiploid, and psuedo/hypodiploid marrow samples. Although there was overlap between the range of values in the three groups, this was minimal between the pseudo/hyperdiploid and pseudo/hypodiploid groups (p = 0 0001). The mean DI of samples from patients with no demonstrable clonal chromosome abnormality, however, was 0 4% lower than that of normal subjects (fig 2) . In addition to the lowering of DI in the diploid group compared with normal subjects, patients in the pseudo/hyperdiploid group group.bmj.com on June 19, 2017 -Published by http://jcp.bmj.com/ Downloaded from the measurement of 10 000 nuclei is far more representative of the total population, though it is less sensitive to minor degrees of DNA loss and cannot detect balanced translocations.
In the present series 21 of 54 patients were found to have a clonal karyotype abnormality but an additional five cases had a DI outside the range found in normal subjects, providing evidence of aneuploidy that was not obtainable from the chromosome preparations. Eight further cases were not included in the present analysis as insufficient metaphases were available for karyotype analysis. Of these, five had a normal DI; in two the DI was low and in one it was high. In both patients with a low DI karyotype analysis carried out on other occasions showed abnormal clones. Poor proliferation of haemopoietic cells is often found in marrow cultures from patients with MDS, and Barlogie et al have pointed out that under such circumstances the use of DNA cytometry can give an indication of ploidy independent of proliferative activity.67 During the period of this study DI measurements were made on marrow samples from an additional 41 patients with MDS in whom chromosome preparations were not made. Twenty eight of these had a normal DI, in six the DI was low, and in seven it was abnormally high. Smets et al, reviewing their study of childhood acute lymphoblastic leukaemia, concluded that the two techniques of chromosome analysis and flow cytometry analysis of DNA should be used jointly, to obtain the maximum amount of genetic information on the leukaemic cell population. 5 Barlogie et al came to a similar conclusion with regard to patients with adult acute leukaemia and pointed out that the two techniques are complementary.! Our own experience, showing the importance of DNA hypoploidy in predicting prognosis,9 and the present data comparing DNA ploidy and chromsome analysis, lead us to draw the same conclusion for patients with MDS.
